Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,460,770
+$198,241 QoQ
Shares Held
5,805
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,204
of 4,172 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026T. Rowe Price Investment Management, Inc. holds $130,347,685 across 8 Drug Manufacturers - General names. ABBV ranks #5 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
50,482 | $60,549,630 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
276,379 | $34,917,722 | |
| 3 | BIIB |
Biogen Inc.
|
113,873 | $24,603,400 | |
| 4 | JNJ |
Johnson & Johnson
|
19,637 | $4,987,208 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
5,805 | $1,460,770 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
24,400 | $1,405,928 | |
| 7 | PFE |
Pfizer Inc
|
56,140 | $1,351,851 | |
| 8 | MRK |
Merck & Co., Inc.
|
8,336 | $1,071,176 |
All Filings in ABBV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,460,770 | 5,805 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,262,529 | 5,805 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,299,825 | 23,195 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,336,975 | 18,731 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $217,473,505 | 1,171,606 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $242,885,850 | 1,159,249 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,066,200 | 6,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $921,679,643 | 4,667,205 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $827,706,293 | 4,825,713 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $880,796,212 | 4,836,882 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $750,384,576 | 4,842,128 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $931,804,617 | 6,251,205 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $808,051,393 | 5,997,561 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,210,814,053 | 7,597,503 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $530,069,810 | 3,279,932 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||